Ipsen (France)
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on transformative medicines in three therapeutic areas: oncology, rare disease and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical companies in terms of oncology sales. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Ipsen (France), France, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
49%
Total
Publications
1.7K
Total Open
Publications
828
Total
Citations
28K
Open Access
Percentage
49%
Total
Publications
1.7K
Total Open
Publications
828
Total
Citations
28K
Breakdown
Publisher Open
19%
Both
24%
Other Platform Open
5%
Closed
52%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 27%
199
Hybrid 55%
403
No Guarantees 18%
135
Other Platform Open
Domain 74%
372
Institution 31%
154
Other Internet 17%
83
Public 10%
50
Preprint 6%
30
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 371 |
Europe PMC | Domain | 210 |
Semantic Scholar | Public | 37 |
Unknown Repository | Other Internet | 34 |
University College London - UCL Discovery | Institution | 24 |
Research Square | Preprint | 14 |
Figshare | Public | 14 |
Le Centre pour la Communication Scientifique Directe - HAL - Inserm | Institution | 12 |
Le Centre pour la Communication Scientifique Directe - HAL - Inria | Institution | 11 |
bioRxiv | Preprint | 11 |